News for Adamis Pharmaceuticals Corporation (0A4X.L)

As per the report by Fortune Business Insights, The Epinephrine Market size is projected to reach USD 4.08 Billion by 2030, at a CAGR of 11.3% during the...

Compounding pharmacies in the US are experiencing high demand for medications that treat mild ailments, promote sleep, strengthen the immune system, lessen...

Company to begin trading under new ticker symbol “DMK” on September 8, 2023...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ...

SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) --  Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.50 A.M. ET)..

The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.50 A.M. ET)..

U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate decision by the Fed.